Humana increased operating profit and improved adjusted margin

Humana reported Q3 revenue of SEK 2,592m, up 4% YoY, with adjusted operating profit increasing 6% to SEK 221m. EBITDA rose to SEK 360m, and net profit reached SEK 123m. Growth was driven by price increases and efficiency improvements in Sweden, while Norway showed strong organic growth. Humana was acquired by Ambea and will delist from Nasdaq Stockholm. The company did not provide a new earnings forecast.

Original reporting
Published Oct 22, 2026, 6:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 6:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$HUM
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

Med
01

Why it matters

The earnings beat and margin improvement suggest operational strength, but the upcoming delisting introduces execution risk.

02

Market read

The earnings release provides fresh data for traders focused on Nordic health‑care stocks, while the delisting adds a short‑term risk factor.

03

What to watch

Potential integration challenges with Ambea and the impact of the pending delisting on liquidity.

Relevance 7/10Novelty 8/10Timing: today

Background

Humana reported Q3 2026 results with modest revenue growth and improved margins, followed by completion of its acquisition by Ambea and a pending delisting from Nasdaq Stockholm.

Market effects

Swedish healthcare services earnings may influence peer valuations in the Nordic health‑care sector.

Positive surprise could lift broader Stockholm exchange sentiment in the short term.

Limited; primarily a regional impact on European health‑care stocks.

Counterpoint

Despite earnings beat, the delisting and integration risk post‑acquisition could pressure the stock.

Key entities

  • Humana

    Swedish health‑care provider reporting Q3 2026 results.

  • Ambea

    Acquirer of Humana, completed the transaction.

Related articles

$UNHMed

UnitedHealthcare and Humana cut Medicare Advantage plans for 1 mn

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans covering nearly 1 million members, withdrawing from less profitable markets. UnitedHealthcare is ending plans for 390,000 members, while Humana is cutting 600,000. Both companies are focusing on more profitable products and regions, according to reports. Rising medical costs are driving these changes, with insurers reducing flexible PPO plans and increasing out-of-pocket expenses for members.

$HUMMed

UnitedHealthcare and Humana Drop Medicare Advantage Plans for Almost 1 Million Seniors

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans affecting nearly 1 million Americans in 2027, citing higher medical expenses and profitability pressures. UnitedHealthcare will impact 390,000 members, focusing on PPO plans, while Humana will affect 600,000 members, targeting lower-performing plans. Both companies are also scaling back certain benefits for 2027, with UnitedHealthcare reducing dental benefits and Humana adjusting premium givebacks.

$HUMMed

Humana’s $2.8 bn BlackRock deal follows Medicare Advantage ratings recovery

Humana (HUM) agreed to a $2.8 bn deal with BlackRock, restructuring ownership of 150 CenterWell clinics. BlackRock acquires WCAS's majority stake, with Humana retaining minority ownership. The deal reduces Humana's balance sheet obligations. Humana's Medicare Advantage star ratings improved, potentially increasing 2028 bonus payments to $4.8 bn, per Evercore ISI. S&P affirmed Humana's BBB rating but maintained a negative outlook.

$HUMMedAI 9/10

Seniors at About 150 CenterWell Clinics Face New Majority Owner as BlackRock Replaces Private Equity Backer

Humana announced that BlackRock's HPS Investment Partners will acquire Welsh Carson's stake in about 150 CenterWell clinics, valued at $2.8B. The deal, expected to close in Q4 2026, will make BlackRock the majority owner, with CenterWell retaining a minority stake and operational control. Humana stated patient care will remain unchanged, and the deal is not expected to materially affect its 2026 earnings guidance.

$HUMMedAI 8/10

Humana, BlackRock Strike $2.8 Bn Deal for CenterWell Clinics

Humana and BlackRock's HPS Investment Partners will form a joint venture to operate and expand CenterWell clinics, with BlackRock acquiring WCAS's stake for $2.8B. The deal aims to provide growth capital and lower costs for Humana, with no disruption to patient care. Humana may repurchase clinics starting 2028. The transaction is expected to close in Q4 2026, with no impact on 2026 earnings guidance.

$HUMMed

What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care

Humana (NYSE: HUM) announced a joint venture with BlackRock to manage 150 CenterWell clinics, while Village Medical divested 27 clinics to Harbor Health. These moves suggest a shift in the senior-focused primary care industry, with changes in ownership and financing strategies. Humana's deal includes a $2.8 billion equity acquisition and potential clinic purchases by CenterWell starting in 2028.